Comparison of the Evaluation of CAD by CT AngioScan and Coronary Angiogram (CTAS-MCAS)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Université de Sherbrooke.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Université de Sherbrooke
First received: January 28, 2013
Last updated: January 29, 2013
Last verified: January 2013
The use of CT Coronary Angioscan (CT-AS) is gaining popularity, but its exact value as evaluation of CAD requires confirmation. We intend to compare the results of CT-AS and convention coronary angiogram results in patients who are scheduled for an ascending aorta aneurysm reparation surgery. These examens are standard of care before this surgery, so there is no additional danger or disadvantage for the patient. We hope to confirm that CT-AS is a reliable screening test for CAD in patient undergoing heart surgery for other reason than CAD.
||Observational Model: Cohort
Time Perspective: Prospective
||Comparison of the Evaluation of CAD by CT AngioScan and Coronary Angiogram in Patient as Part of Preoperative Evaluation in Ascending Aorta Replacement Surgery Patients.
Primary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||February 2015 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years to 89 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Patients with ascending aorta aneurysm undergoing preoperative evaluation of CAD by CT-Angioscan and Coronary angiogramm before surgical reparation.
- Ascending aorta aneurysm waiting for surgical correction
- Willing to participate
- Needing a Coronary angiogram and a CT-AS for medical reasons
- Refuse to participate
- Allergy to contrast material
- Incomplete results or having one of the test done in another hospital
- More than 6 months between the two exams
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01779986
|Sherbrooke, Quebec, Canada, J1H 5N4 |
|Contact: Paul Farand, M.Sc 819-346-1110 email@example.com |
|Principal Investigator: Gérald Gahide, MD |
|Sub-Investigator: Paul Farand, MD, MSc |
|Sub-Investigator: Tamas Z Fulop, MD |
|Sub-Investigator: Francis Rivest, MD |
Université de Sherbrooke
||Gerald Gahide, MD PHD
||Universite de Sherbrooke
No publications provided
||Université de Sherbrooke
History of Changes
|Other Study ID Numbers:
||CTAS-MCAS UdeS 12-073
|Study First Received:
||January 28, 2013
||January 29, 2013
||Canada: Ethics Review Committee
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 01, 2015
Coronary Artery Disease
Arterial Occlusive Diseases